Safety, tolerability, pharmacokinetics, and pharmacodynamics of TG103 injection in participants who are overweight or obese: a randomized, double-blind, placebo-controlled, multiple-dose phase 1b studyDiaozhu Lin, Li Yan, Juan Li et al.|BMC Medicine|2024Cited by 5
Development and validation of a nomogram for assessing risk of isolated high 2-hour plasma glucoseKan Sun, Xianchao Xiao, Lili You et al.|Frontiers in Endocrinology|2022Cited by 1